Close Menu

web services

The Wellcome Trust has granted the University of Dundee five more years of support to help bioinformaticians develop a web-compatible JavaScript version of the software.

Genome-wide polygenic risk scores highlight those at risk of coronary artery disease, atrial fibrillation, type 2 diabetes, IBD, and breast cancer.

Researchers got together at the ISMB/ECCB conference to create, clean up, and organize Wikipedia articles on biomedical informatics.

The telegenomics startup will use the proceeds to support the rollout of its genetic consultation services. A pilot version of the services was launched last fall.

Tamr's software may help researchers involved in the project to organize, unify, and integrate large quantities of genomic and other data for analysis.

Era7 is leading an effort to develop a platform for analyzing patient microbiomes that could be integrated with hospitals' EHRs.

SAP has released products for integrating and analyzing structured and unstructured clinical and genomic datasets, and supporting patient cohort analysis.

As newly-minted GenoFAB mulls commercial models for its GenoCAD DNA design web app, the company is trying to engage with its target market through pilot projects.

Genentech developed Unison to reduce the amount of time researchers spent on data preparation prior to bioinformatics analysis. Recognizing that many scientists outside the company are grappling with the same issues, they decided to release the system under the open-source Academic Free License.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.